MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Late-Onset Bulbar-Predominant Neurodegeneration Associated With a Truncating AFG3L2 Variant: Expanding the Clinical Spectrum of AFG3L2-Related Disease

    R. Sharma, A. Higinbotham, C. Chambers, G. Solorzano (Charlottesville, USA)

    Objective: To describe an atypical late-onset, bulbar-predominant neurodegenerative presentation associated with a heterozygous truncating AFG3L2 variant and contextualize this phenotype within the expanding spectrum of…
  • 2026 International Congress

    Association of Neurofilament Light Chain with Substantia Nigra Degeneration in Parkinson’s Disease

    WJ. Wu, WQ. Jiang, QY. Zheng, L. Luo, Y. Zhang, XY. Zhang, ZM. Dong, ZY. Yu, T. Wu, XJ. Dai, DL. Zhang (Beijing, China)

    Objective: This study aims to investigate the association between serum neurofilament light chain (NfL), microstructural changes in the substantia nigra, and clinical manifestations in Parkinson’s…
  • 2026 International Congress

    Revisiting the Association between Estrogen Exposure and Parkinson’s Disease: A Fox Insight Analysis

    S. Dharmadhikari, V. Dumoulin, S. Karim, M. Afshari (Chicago, USA)

    Objective: To evaluate the association between markers of lifetime estrogen exposure and Parkinson’s Disease (PD) in a large digital cohort of postmenopausal women. Background: The…
  • 2026 International Congress

    Evaluating the Conversion of Immediate-Release and/or Extended-Release Levodopa to IPX203 in Patients with Parkinson’s Disease

    L. Poon, A. Lee, D. Lee, T. Chiao, T. Stiep (San Francisco, USA)

    Objective: This quality improvement (QI) project was conducted to evaluate the impact of the conversion from immediate-release (IR) and/or extended-release (ER) levodopa (LD) to mucoadhesive polymer…
  • 2026 International Congress

    Cholinergic Basal Forebrain Atrophy Associates with Short-Latency Afferent Inhibition and Cognitive Impairment in Parkinson’s Disease

    JF. Martín-Rodríguez, P. Franco-Rosado, C. Perez-Calvo, E. Iglesias-Camacho, M. San-Eufrasio, A. Castellano-Guerrero, FJ. Gómez-Campos, P. Díaz-Galván, MA. Labrador-Espinosa, J. Silva-Rodríguez, AC. Luque Ambrosiani, E. Ojeda-Lepe, L. Muñoz-Delgado, D. Macías-García, A. Adarmes-Gómez, S. Jesus, F. Carrillo, F. Roldan Lora, MJ. Grothe, P. Mir (Sevilla, Spain)

    Objective: To investigate whether cholinergic basal forebrain (cBF) atrophy mediates the relationship between short-latency afferent inhibition (SAI) and cognitive performance in PD. Background: Cognitive impairment…
  • 2026 International Congress

    Electrocardiographic Indicators of Autonomic Dysfunction in Parkinson’s Disease: A Scoping Review and Meta-analysis

    I. Serag, A. Negida (Mansoura, Egypt)

    Objective: To systematically map and quantitatively synthesize evidence on ECG-derived markers associated with autonomic dysfunction in PD and evaluate their ability to differentiate patients from…
  • 2026 International Congress

    REM Sleep Behaviour Disorder and early non-motor symptoms in Parkinson’s Disease

    HT. Lim, S. Ng, XY. Choi, D. Heng, ZY. Xu, S. Neo, KY. Tay, WL. Au, DX. Deng, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: To investigate early non-motor symptoms between the RBD-positive and RBD-negative PD patients from the Early Parkinson’s Disease Longitudinal Singapore study (PALS) cohort. Background: REM…
  • 2026 International Congress

    Quantitative Neurodegenerative Risk Modelling and Clinical Score Prediction Using Mixed Reality

    J. Stępień, M. Baran, W. Szecówka, N. Bozetine, M. Dudek, J. Krzywdziak, M. żbik, J. Sikora, D. Hemmerling, M. Wójcik-Pędziwiatr (Kraków, Poland)

    Objective: This study investigates the potential of mixed reality (MR) tool for multimodal data collection from individuals with Parkinson’s disease and examines the use of…
  • 2026 International Congress

    Altered Motor Regulation and Limbic-Motor Circuits in Paroxysmal Kinesigenic Dyskinesia

    XJ. Huang, ZY. Li, Y. Yuan, Y. Guan, Y. Li, L. Cao (Shanghai, China)

    Objective: To explore underlying circuit-level mechanisms in paroxysmal kinesigenic dyskinesia (PKD). Background: While the cortico-striato-thalamo-cortical loop and cerebellum are implicated in PKD pathophysiology, the causal…
  • 2026 International Congress

    Two-year Outcomes of Rapid Eye Movement Behavior Disorder Following Globus Pallidus Interna Deep Brain Stimulation for Parkinson’s Disease

    J. Zuzuarregui, A. Wiltshire, A. Mahes, S. Wang, M. San Luciano (San Francisco, USA)

    Objective: This study evaluated two-year outcomes of rapid eye movement (REM) sleep behavior disorder (RBD) in a cohort of patients with Parkinson’s disease (PD) who…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley